Precigen, Inc. (PGEN)

$1.00 -6.07% $-0.06 Healthcare

Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.

$289.50M

Dr. Helen Sabzevari MPH, Ph.D.

456.00

Germantown, MD

Aug 08, 2013

-1.86

$-0.54

0.41

1.03

-142.95%

-9.57

-1.14

6.26

15.62

1.03

-38.56%

-27.77%

Similar stocks (12)

Protagonist Therapeutics, Inc.

PTGX

$46.56 1.38%
Uptrend

Edgewise Therapeutics, Inc.

EWTX

$28.25 -4.24%
Uptrend

Syndax Pharmaceuticals, Inc.

SNDX

$18.61 -0.11%
Downtrend

Day One Biopharmaceuticals, Inc.

DAWN

$14.40 0.59%
Downtrend

CorMedix Inc.

CRMD

$7.07 0.86%
Uptrend

Corvus Pharmaceuticals, Inc.

CRVS

$5.86 4.53%
Uptrend

Inozyme Pharma, Inc.

INZY

$5.75 -0.52%
Uptrend

Sangamo Therapeutics, Inc.

SGMO

$0.90 0.00%
Uptrend

Agenus Inc.

AGEN

$6.23 4.01%
Downtrend

Leap Therapeutics, Inc.

LPTX

$2.80 -1.41%
Neutral

Marker Therapeutics, Inc.

MRKR

$2.90 -1.05%
Downtrend

Galera Therapeutics, Inc.

GRTX

$0.08 0.00%
Downtrend

ETF Exposure (29)

iShares Micro-Cap ETF

IWC

0.03302%

$125.07 -1.16%
Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.024%

$24.51 -0.61%
Uptrend

iShares Biotechnology ETF

IBB

0.01183%

$148.25 -0.82%
Uptrend

Vanguard Russell 2000 Index Fund

VTWO

0.01%

$89.98 -0.66%
Uptrend

Vanguard Russell 2000 Value Index Fund

VTWV

0.01%

$148.58 -1.16%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.00858%

$168.66 -1.02%
Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.006983844239963117%

$67.30 -1.36%
Uptrend

Schwab U.S. Small-Cap ETF

SCHA

0.0058323885%

$51.61 -0.67%
Uptrend

iShares Russell 2000 ETF

IWM

0.00489%

$222.27 -0.76%
Uptrend

WisdomTree BioRevolution Fund

WDNA

0.0027864%

$16.81 -0.68%
Uptrend

ProShares Ultra Russell2000

UWM

0.0017980326932941946%

$43.45 -1.45%
Uptrend

ProShares UltraPro Russell2000

URTY

8.86400670476147e-4%

$53.08 -2.19%
Uptrend

iShares Russell 2000 Growth ETF

IWO

8.3e-4%

$284.51 -0.44%
Uptrend

ProShares Hedge Replication ETF

HDG

7.540389661717196e-4%

$50.07 0.41%
Uptrend

Schwab U.S. Broad Market ETF

SCHB

5.423963e-4%

$65.93 -0.47%
Uptrend

iShares Russell 3000 ETF

IWV

4.1e-4%

$324.56 -0.33%
Uptrend

iShares MSCI USA Small-Cap Multifactor ETF

SMLF

0%

$66.21 -0.72%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Russell 3000 Index Fund

VTHR

0%

$252.26 -0.32%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$280.92 -0.40%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend

Vanguard Russell 2000 Growth Index Fund

VTWG

0%

$207.01 -0.62%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$181.43 -0.81%
Uptrend